# Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

> **NCT00553488** · PHASE2 · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 30 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Regular insulin (Humulin)
- **DRUG:** Insulin lispro (Humalog)

## Key facts

- **NCT ID:** NCT00553488
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00553488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00553488, "Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00553488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*